ECHA updates information for companies on UK withdrawal from EU
ECHA has updated the Q&As providing advice to companies on the UK’s withdrawal from the EU. The updates cover topics related to the authorisation and registration of substances and mixtures under REACH, as well as general advice to current non-EU companies. The updates also provide advice on transferring assets between a company’s affiliates.
ECHA will publish new Q&As related to the Biocidal Products Regulation (BPR) soon.
ECHA does not plan to significantly expand its Q&As ahead of the date of the UK’s withdrawal on 30 March 2019. However, companies are recommended to check for updates in the coming months.
The advice is written on the basis that the UK’s withdrawal will take effect on 30 March 2019. If the EU and the UK conclude a withdrawal agreement and therein agree on a transition period, ECHA will amend the Q&As accordingly.
ECHA is committed to providing user-friendly and timely advice to companies on developments regarding the UK’s withdrawal from the EU, and will soon publish a revamped version of the relevant web section on its website.
2026-10-18
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
EU Chemicals Regulatory Update: Practical Compliance Actions Following ECHA January 2026 Developments
-
L'Oréal UK sales hit £1.5 billion
-
Pesticide Usage in Scotland--Outdoor Vegetable Crops 2021
-
The British chemical industry is in trouble
-
British malters use malt in plant-based meat products
-
Britain considers banning solid urea
-
Triggered by the epidemic, the UK chemical market faces multiple blows
-
U.K. endorses dexamethasone in COVID-19 hours after groundbreaking data release
-
UK trials remdesivir treatment for COVID-19 as UK PM aide row rages on
-
Indena aescin active ingredient successfully registered REACH
Recommend Reading
-
FDA Color Policy Uncertainty Opens a New Chapter for Food Ingredient Reform
-
India Proposes New GMP Rules for Clinical Trial and API Manufacturing
-
2026 Q1 Chemical Giant Earnings: Supply Contraction, Flat Demand, Full-Scale "Defense Priority"
-
UK’s £350 Million Critical Chemicals Fund Enters Formal Review, Offering Up to 50% Support Per Project
-
South Korea’s Largest Petrochemical Hub Moves to Cut Cracker Capacity by 40%
-
Downstream Urgent Purchases Drive Acrylic Market to Decline
-
Warehouse Receipt Cancellation Fuels Market Sentiment, Driving Lithium Carbonate Prices Higher
-
Both Supply and Demand Weak, PCs in Volatile Operation Mid-May
-
Applications of Caesium Iodide
-
Styrene-Butadiene Rubber Market Struggles to Find Direction